[HTML][HTML] Therapeutics for COVID-19 and post COVID-19 complications: An update
Since its inception in late December 2020 in China, novel coronavirus has affected the
global socio-economic aspect. Currently, the world is seeking safe and effective treatment …
global socio-economic aspect. Currently, the world is seeking safe and effective treatment …
Continuous flow asymmetric synthesis of chiral active pharmaceutical ingredients and their advanced intermediates
Catalytic enantioselective transformations provide well-established and direct access to
stereogenic synthons that are broadly distributed among active pharmaceutical ingredients …
stereogenic synthons that are broadly distributed among active pharmaceutical ingredients …
The mechanism underlying extrapulmonary complications of the coronavirus disease 2019 and its therapeutic implication
Q Ning, D Wu, X Wang, D Xi, T Chen, G Chen… - Signal transduction and …, 2022 - nature.com
Abstract The coronavirus disease 2019 (COVID-19) is a highly transmissible disease
caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that poses a …
caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that poses a …
Potential therapeutic targets and vaccine development for SARS-CoV-2/COVID-19 pandemic management: a review on the recent update
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a highly pathogenic
novel virus that has caused a massive pandemic called coronavirus disease 2019 (COVID …
novel virus that has caused a massive pandemic called coronavirus disease 2019 (COVID …
[HTML][HTML] SARS-CoV-2 E protein: Pathogenesis and potential therapeutic development
S Zhou, P Lv, M Li, Z Chen, H Xin, S Reilly… - Biomedicine & …, 2023 - Elsevier
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a devastating
global pandemic, which has seriously affected human health worldwide. The discovery of …
global pandemic, which has seriously affected human health worldwide. The discovery of …
Investigating the aggressiveness of the COVID-19 Omicron variant and suggestions for possible treatment options
MD Mohiuddin, K Kasahara - Respiratory Medicine, 2022 - Elsevier
The COVID-19 pandemic has put a strain on all the healthcare systems around the world.
The World Health Organization (WHO) stated that the “highly mutated” Omicron variant …
The World Health Organization (WHO) stated that the “highly mutated” Omicron variant …
Antiphospholipid antibodies and risk of post-COVID-19 vaccination thrombophilia: The straw that breaks the camel's back?
R Talotta, ES Robertson - Cytokine & growth factor reviews, 2021 - Elsevier
Antiphospholipid antibodies (aPLs), present in 1–5% of healthy individuals, are associated
with the risk of antiphospholipid syndrome (APS), which is the most common form of …
with the risk of antiphospholipid syndrome (APS), which is the most common form of …
A review of the presence of SARS-CoV-2 RNA in wastewater and airborne particulates and its use for virus spreading surveillance
According to the WHO, on October 16, 2020, the spreading of the SARS-CoV-2, responsible
for the COVID-19 pandemic, reached 235 countries and territories, and resulting in more …
for the COVID-19 pandemic, reached 235 countries and territories, and resulting in more …
Repurposing the estrogen receptor modulator raloxifene to treat SARS-CoV-2 infection
The ongoing coronavirus disease 2019 (COVID-19) pandemic caused by the novel severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) necessitates strategies to identify …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) necessitates strategies to identify …
Mesenchymal stem cell-based treatments for COVID-19: status and future perspectives for clinical applications
L Chen, J Qu, FS Kalyani, Q Zhang, L Fan… - Cellular and Molecular …, 2022 - Springer
As a result of cross-species transmission in December 2019, the coronavirus disease 2019
(COVID-19) became a serious endangerment to human health and the causal agent of a …
(COVID-19) became a serious endangerment to human health and the causal agent of a …